Medical Prognosis Institute A/S (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Medical Prognosis Institute A/S (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Medical Prognosis Institute A/S (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Medical Prognosis Institute A/S (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 22, 2016
24 pages — Published Sep 22, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Medical Prognosis Institute A/S (MPI) is a pharmaceutical company that offers cancer treatment solutions. The company offers drp platform that provides tool for rationalized drug development and personalized medicine. It provides lead compound selection, drug rescue repositioning repurposing, patient selection, drug combinations, pathway elucidation, new indications, indication selection and companion diagnostic programs. MPI also provides drug specific interface to the human genome and predict drug response in individual patients. The company has partnerships with various cancer drug developing companies. It has its presence in Denmark and the US. MPI is headquartered in Horsholm, Denmark

Medical Prognosis Institute A/S (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key

  
Source:
Document ID
GDPH110071D
Country
Industry
Ticker
MPI=DK
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Medical Prognosis Institute A/S, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Medical Prognosis Institute A/S, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Medical Prognosis Institute A/S, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Medical Prognosis Institute A/S, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Medical Prognosis Institute A/S, Medical Devices Deals, 2010 to YTD 201691
Medical Prognosis Institute A/S, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Medical Prognosis Institute A/S, Pharmaceuticals &Healthcare, Deal Details1110
  Venture Financing111
    Oncology Venture Raises USD0.56 Million in Venture Financing111
  Partnerships121
    Medical Prognosis Institute Enters into Agreement with Mundipharma EDO121
    Medical Prognosis Institute Enters into Co-Development Agreement with Nemucore Medical Innovations131
    Medical Prognosis Institute Enters into Co-Development Agreement with Alion Pharma141
  Licensing Agreements151
    Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute151
  Equity Offering161
    Medical Prognosis Institute Raises USD1.3 Million in Private Placement of Shares161
    Medical Prognosis Institute Raises USD1 Million in Private Placement of Shares171
    Medical Prognosis Raises USD0.003 Million in Private Placement of Shares upon Exercise of Warrants181
    Medical Prognosis Raises USD1.7 Million in Rights Issue of Shares191
  Asset Transactions201
    Oncology Venture Acquires Drug Response Predictor from Medical Prognosis Institute201
Medical Prognosis Institute A/S - Key Competitors211
Key Employees221
Locations And Subsidiaries231
  Head Office231
  Other Locations &Subsidiaries231
Appendix241
  Methodology241
  About GlobalData241
  Contact Us241
  Disclaimer241

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Medical Prognosis Institute A/S (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 22, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Medical-Prognosis-Institute-A-S-MPI-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23402>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Medical Prognosis Institute A/S (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 22, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Medical-Prognosis-Institute-A-S-MPI-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23402>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research